IRIDEX Corporation - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
IRIX Nasdaq 3840 www.iridex.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for IRIDEX Corporation

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema - Jun 24th, 2025 5:00 am
IRIDEX Corp (IRIX) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Investments ... - May 14th, 2025 1:17 am
Iridex: Q1 Earnings Snapshot - May 13th, 2025 2:33 pm
Iridex Reports First Quarter 2025 Financial Results - May 13th, 2025 2:05 pm
Iridex to Report First Quarter 2025 Financial Results on May 13, 2025 - Apr 30th, 2025 2:05 pm
Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025 - Apr 14th, 2025 2:05 pm
Iridex to Host Strategic Vision Call on April 16, 2025 - Apr 9th, 2025 2:05 pm
IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic Investments and Revenue Growth ... - Mar 28th, 2025 1:04 am
Iridex: Q4 Earnings Snapshot - Mar 27th, 2025 2:36 pm
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results - Mar 27th, 2025 2:05 pm
Iridex Announces Strategic Investment in the Company - Mar 19th, 2025 7:15 am
Iridex Comments on Recent Stock Price Volatility - Mar 14th, 2025 5:00 am
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 - Mar 13th, 2025 3:00 pm
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024 - Jan 14th, 2025 5:00 am
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management - Dec 18th, 2024 2:05 pm
Iridex Comments on Changing Glaucoma Reimbursement Landscape - Nov 19th, 2024 6:14 am
3 US Penny Stocks With Market Caps Under $50M To Watch - Nov 14th, 2024 6:09 am
IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ... - Nov 13th, 2024 12:20 am
Iridex: Q3 Earnings Snapshot - Nov 12th, 2024 2:40 pm
Iridex Reports Third Quarter 2024 Financial Results - Nov 12th, 2024 2:05 pm